With the advent of PERK specific inhibitors and an eye towards therapeutic utility, we have addressed the role of PERK in BrafV600E driven melanoma and provide evidence for a dose-dependent function of PERK in melanoma genesis. The gene discussed is EIF2AK3; the disease is melanoma.